AI-generated summary
The authors retrospectively reviewed 49 patients with Becker's nevus treated with a 1064-nm Nd:YAG picosecond laser at one center, with improvement rated from photographs by two dermatologists. They report the treatment was well tolerated with transient adverse events, and that among patients without hypertrichosis the number of sessions correlated with efficacy. The design is single-center and retrospective, without a control group.
- Participants
- 49
- Who or what was studied
- Patients with Becker's nevus treated between March 2021 and August 2025 in a Chinese population (18 females, 31 males); 24 had hypertrichosis and 25 did not.
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The study is single-center, retrospective, and has no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.